Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: Commentary.

In differential diagnosis with MS and neuromyelitis optica spectrum disorders (NMOSD), myelin oligodendrocyte glycoprotein IgG- (MOG-IgG)-associated disorders (MOGAD) manifest as heterogeneous clinical phenotypes. Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study. [Extracted from the article]

Copyright of Multiple Sclerosis Journal is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)